img

Global and United States Non-Steroidal Anti-Inflammatory Drugs Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Non-Steroidal Anti-Inflammatory Drugs Market Report & Forecast 2024-2034

Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
Market Analysis and InsightsGlobal and United States Non-Steroidal Anti-Inflammatory Drugs Market
This report focuses on global and United States Non-Steroidal Anti-Inflammatory Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Non-Steroidal Anti-Inflammatory Drugs revenue was US$ 20600 million in 2024 and is forecast to a readjusted size of US$ 29690 million by 2034 with a CAGR of 5.4% during the review period (2024-2034).
In United States the Non-Steroidal Anti-Inflammatory Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Non-Steroidal Anti-Inflammatory Drugs include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc. The global five biggest players hold a share of % in 2024.
Global Non-Steroidal Anti-Inflammatory Drugs Scope and Market Size
Non-Steroidal Anti-Inflammatory Drugs market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Non-Steroidal Anti-Inflammatory Drugs market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Pfizer Inc.
Bayer AG
GSK plc
Dr. Reddy’s Laboratories Ltd
Viatris Inc
Teva Pharmaceutical Industries Ltd.
Johnson And Johnson Services, Inc.
Merck & Co., Inc.
Segment by Type
Non-Selective NSAIDs
COX-2 Selective NSAIDs

Segment by Application


Dental Pain
Muscle Aches
Pain caused by Gout
Bursitis
Menstrual Cramps
Fever
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Non-Steroidal Anti-Inflammatory Drugs definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Non-Steroidal Anti-Inflammatory Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Steroidal Anti-Inflammatory Drugs revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Non-Steroidal Anti-Inflammatory Drugs Product Introduction
1.2 Global Non-Steroidal Anti-Inflammatory Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size for the Year 2018-2034
1.2.2 United States Non-Steroidal Anti-Inflammatory Drugs Market Size for the Year 2018-2034
1.3 Non-Steroidal Anti-Inflammatory Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Non-Steroidal Anti-Inflammatory Drugs in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Non-Steroidal Anti-Inflammatory Drugs Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Non-Steroidal Anti-Inflammatory Drugs Market Dynamics
1.4.1 Non-Steroidal Anti-Inflammatory Drugs Industry Trends
1.4.2 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
1.4.3 Non-Steroidal Anti-Inflammatory Drugs Market Challenges
1.4.4 Non-Steroidal Anti-Inflammatory Drugs Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Non-Steroidal Anti-Inflammatory Drugs by Type
2.1 Non-Steroidal Anti-Inflammatory Drugs Market Segment by Type
2.1.1 Non-Selective NSAIDs
2.1.2 COX-2 Selective NSAIDs
2.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018, 2024 & 2034)
2.3 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2034)
2.4 United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018, 2024 & 2034)
2.5 United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2034)
3 Non-Steroidal Anti-Inflammatory Drugs by Application
3.1 Non-Steroidal Anti-Inflammatory Drugs Market Segment by Application
3.1.1 Dental Pain
3.1.2 Muscle Aches
3.1.3 Pain caused by Gout
3.1.4 Bursitis
3.1.5 Menstrual Cramps
3.1.6 Fever
3.1.7 Others
3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018, 2024 & 2034)
3.3 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2034)
3.4 United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018, 2024 & 2034)
3.5 United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2034)
4 Global Non-Steroidal Anti-Inflammatory Drugs Competitor Landscape by Company
4.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Company
4.1.1 Global Key Companies of Non-Steroidal Anti-Inflammatory Drugs, Ranked by Revenue (2024)
4.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2018-2023)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Concentration Ratio (CR)
4.2.1 Non-Steroidal Anti-Inflammatory Drugs Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Steroidal Anti-Inflammatory Drugs in 2024
4.2.3 Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs Head office and Area Served
4.4 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Product and Application
4.5 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Company
4.7.1 Key Players of Non-Steroidal Anti-Inflammatory Drugs in United States, Ranked by Revenue (2024)
4.7.2 United States Non-Steroidal Anti-Inflammatory Drugs Revenue by Players (2021, 2024 & 2023)
5 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region
5.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2018-2034)
5.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2018-2023
5.2.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2024-2034)
6 Americas
6.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth 2018-2034
6.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
6.2.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
6.2.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034)
6.2.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
6.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
6.3.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
6.3.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034)
6.3.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
6.4 Americas Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
7.2.1 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
7.2.2 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034)
7.2.3 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
7.3 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
7.3.1 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
7.3.2 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034)
7.3.3 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
7.4 EMEA Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth 2018-2034
8.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
8.2.1 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
8.2.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034)
8.2.3 China Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
8.3 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
8.3.1 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
8.3.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034)
8.3.3 China Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth 2018-2034
9.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
9.2.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023)
9.2.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034)
9.2.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
9.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
9.3.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023)
9.3.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034)
9.3.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
9.4 APAC Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Details
10.1.2 Pfizer Inc. Business Overview
10.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
10.1.4 Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.1.5 Pfizer Inc. Recent Development
10.2 Bayer AG
10.2.1 Bayer AG Company Details
10.2.2 Bayer AG Business Overview
10.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Introduction
10.2.4 Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.2.5 Bayer AG Recent Development
10.3 GSK plc
10.3.1 GSK plc Company Details
10.3.2 GSK plc Business Overview
10.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Introduction
10.3.4 GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.3.5 GSK plc Recent Development
10.4 Dr. Reddy’s Laboratories Ltd
10.4.1 Dr. Reddy’s Laboratories Ltd Company Details
10.4.2 Dr. Reddy’s Laboratories Ltd Business Overview
10.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Introduction
10.4.4 Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.4.5 Dr. Reddy’s Laboratories Ltd Recent Development
10.5 Viatris Inc
10.5.1 Viatris Inc Company Details
10.5.2 Viatris Inc Business Overview
10.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Introduction
10.5.4 Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.5.5 Viatris Inc Recent Development
10.6 Teva Pharmaceutical Industries Ltd.
10.6.1 Teva Pharmaceutical Industries Ltd. Company Details
10.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Introduction
10.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.7 Johnson And Johnson Services, Inc.
10.7.1 Johnson And Johnson Services, Inc. Company Details
10.7.2 Johnson And Johnson Services, Inc. Business Overview
10.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
10.7.4 Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.7.5 Johnson And Johnson Services, Inc. Recent Development
10.8 Merck & Co., Inc.
10.8.1 Merck & Co., Inc. Company Details
10.8.2 Merck & Co., Inc. Business Overview
10.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
10.8.4 Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
10.8.5 Merck & Co., Inc. Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Non-Steroidal Anti-Inflammatory Drugs Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Non-Steroidal Anti-Inflammatory Drugs Market Trends
Table 3. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Table 4. Non-Steroidal Anti-Inflammatory Drugs Market Challenges
Table 5. Non-Steroidal Anti-Inflammatory Drugs Market Restraints
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Non-Steroidal Anti-Inflammatory Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Player, 2018-2023
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2024)
Table 15. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Headquarters and Area Served
Table 16. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Product and Application
Table 17. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Non-Steroidal Anti-Inflammatory Drugs in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Non-Steroidal Anti-Inflammatory Drugs Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 51. Pfizer Inc. Company Details
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product
Table 54. Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Bayer AG Company Details
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product
Table 59. Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 60. Bayer AG Recent Development
Table 61. GSK plc Company Details
Table 62. GSK plc Business Overview
Table 63. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product
Table 64. GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 65. GSK plc Recent Development
Table 66. Dr. Reddy’s Laboratories Ltd Company Details
Table 67. Dr. Reddy’s Laboratories Ltd Business Overview
Table 68. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product
Table 69. Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 70. Dr. Reddy’s Laboratories Ltd Recent Development
Table 71. Viatris Inc Company Details
Table 72. Viatris Inc Business Overview
Table 73. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product
Table 74. Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 75. Viatris Inc Recent Development
Table 76. Teva Pharmaceutical Industries Ltd. Company Details
Table 77. Teva Pharmaceutical Industries Ltd. Business Overview
Table 78. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product
Table 79. Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Ltd. Recent Development
Table 81. Johnson And Johnson Services, Inc. Company Details
Table 82. Johnson And Johnson Services, Inc. Business Overview
Table 83. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product
Table 84. Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 85. Johnson And Johnson Services, Inc. Recent Development
Table 86. Merck & Co., Inc. Company Details
Table 87. Merck & Co., Inc. Business Overview
Table 88. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product
Table 89. Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023) & (US$ Million)
Table 90. Merck & Co., Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Market Size 2018-2034 (US$ Million)
Figure 4. United States Non-Steroidal Anti-Inflammatory Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Non-Steroidal Anti-Inflammatory Drugs Market Size 2018-2034 (US$ Million)
Figure 6. United States Non-Steroidal Anti-Inflammatory Drugs Market Share in Global 2018-2034
Figure 7. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 8. Product Picture of Non-Selective NSAIDs
Figure 9. Product Picture of COX-2 Selective NSAIDs
Figure 10. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Type in 2024 & 2034
Figure 11. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 13. United States Non-Steroidal Anti-Inflammatory Drugs Market Share by Type in 2024 & 2034
Figure 14. United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 16. Product Picture of Dental Pain
Figure 17. Product Picture of Muscle Aches
Figure 18. Product Picture of Pain caused by Gout
Figure 19. Product Picture of Bursitis
Figure 20. Product Picture of Menstrual Cramps
Figure 21. Product Picture of Fever
Figure 22. Product Picture of Others
Figure 23. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Application in 2024 & 2034
Figure 24. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2034) & (US$ Million)
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 26. United States Non-Steroidal Anti-Inflammatory Drugs Market Share by Application in 2024 & 2034
Figure 27. United States Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2018-2034) & (US$ Million)
Figure 28. United States Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 29. The Top 5 and 10 Largest Companies of Non-Steroidal Anti-Inflammatory Drugs in the World: Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2024
Figure 30. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 31. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2018-2034)
Figure 32. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 33. Americas Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 34. Americas Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 35. United States Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 40. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 41. EMEA Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 42. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. Middle East Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 44. Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 45. China Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 46. China Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 47. China Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 48. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate 2018-2034 (US$ Million)
Figure 49. APAC Non-Steroidal Anti-Inflammatory Drugs Market Share by Type (2018-2034)
Figure 50. APAC Non-Steroidal Anti-Inflammatory Drugs Market Share by Application (2018-2034)
Figure 51. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. China Taiwan Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 55. India Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 56. Pfizer Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 57. Bayer AG Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 58. GSK plc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 59. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 60. Viatris Inc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 62. Johnson And Johnson Services, Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed